Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue 1
Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study - July 01, 2020
PDF
XML
Clinical/translational cancer immunotherapy
Original research
Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study
Online download statistics by month:
Online download statistics by month: June 2020 to March 2024
Abstract
Full
Pdf
Jun 2020
385
385
121
Jul 2020
260
260
85
Aug 2020
144
140
67
Sep 2020
132
132
93
Oct 2020
78
78
37
Nov 2020
103
103
69
Dec 2020
97
97
35
Jan 2021
99
99
49
Feb 2021
159
159
43
Mar 2021
163
163
47
Apr 2021
100
100
49
May 2021
106
106
59
Jun 2021
120
120
63
Jul 2021
124
124
68
Aug 2021
101
101
49
Sep 2021
131
131
68
Oct 2021
136
135
92
Nov 2021
147
147
104
Dec 2021
145
147
87
Jan 2022
122
128
61
Feb 2022
97
101
65
Mar 2022
128
134
70
Apr 2022
111
117
53
May 2022
147
148
74
Jun 2022
184
185
64
Jul 2022
115
120
43
Aug 2022
127
128
82
Sep 2022
126
127
75
Oct 2022
137
137
64
Nov 2022
156
158
74
Dec 2022
89
89
46
Jan 2023
89
89
68
Feb 2023
135
135
40
Mar 2023
160
161
86
Apr 2023
99
99
43
May 2023
117
117
53
Jun 2023
125
125
54
Jul 2023
116
116
46
Aug 2023
113
117
39
Sep 2023
107
107
34
Oct 2023
100
100
41
Nov 2023
124
124
47
Dec 2023
121
122
59
Jan 2024
107
108
37
Feb 2024
105
107
36
Mar 2024
126
126
69
Total
6013
6052
2808
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?